Deep COVID DeteCT: an international experience on COVID-19 lung detection and prognosis using chest CT

Deep COVID DeteCT: an international experience on COVID-19 lung detection and prognosis using chest CT

Abstract The Coronavirus disease 2019 (COVID-19) presents open questions in how we clinically diagnose and assess disease course. Recently, chest computed tomography (CT) has shown utility for COVID-19 diagnosis. In this study, we developed Deep COVID DeteCT (DCD), a deep learning convolutional neur...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Edward H. Lee, Jimmy Zheng, Errol Colak, Maryam Mohammadzadeh, Golnaz Houshmand, Nicholas Bevins, Felipe Kitamura, Emre Altinmakas, Eduardo Pontes Reis, Jae-Kwang Kim, Chad Klochko, Michelle Han, Sadegh Moradian, Ali Mohammadzadeh, Hashem Sharifian, Hassan Hashemi, Kavous Firouznia, Hossien Ghanaati, Masoumeh Gity, Hakan Doğan, Hojjat Salehinejad, Henrique Alves, Jayne Seekins, Nitamar Abdala, Çetin Atasoy, Hamidreza Pouraliakbar, Majid Maleki, S. Simon Wong, Kristen W. Yeom
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
Computer applications to medicine. Medical informatics
R858-859.7
Accès en ligne:https://doaj.org/article/b8cdd6ddc1174a5a86416c48a44db3cc
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Description
Résumé:Abstract The Coronavirus disease 2019 (COVID-19) presents open questions in how we clinically diagnose and assess disease course. Recently, chest computed tomography (CT) has shown utility for COVID-19 diagnosis. In this study, we developed Deep COVID DeteCT (DCD), a deep learning convolutional neural network (CNN) that uses the entire chest CT volume to automatically predict COVID-19 (COVID+) from non-COVID-19 (COVID−) pneumonia and normal controls. We discuss training strategies and differences in performance across 13 international institutions and 8 countries. The inclusion of non-China sites in training significantly improved classification performance with area under the curve (AUCs) and accuracies above 0.8 on most test sites. Furthermore, using available follow-up scans, we investigate methods to track patient disease course and predict prognosis.

Documents similaires